NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancerBérengère Salomé, Nina Bhardwaj, Brian Lee et al.|Cancer Cell|2022Cited by 127
Small-Molecule Activators of Protein Phosphatase 2A for the Treatment of Castration-Resistant Prostate CancerKimberly McClinch, Matthew D. Galsky, Rita A. Avelar et al.|Cancer Research|2018Cited by 86
Elevated T-cell Exhaustion and Urinary Tumor DNA Levels Are Associated with Bacillus Calmette-Guérin Failure in Patients with Non–muscle-invasive Bladder CancerTrine Strandgaard, Lars Dyrskjøt, Sia V. Lindskrog et al.|European Urology|2022Cited by 74
Diagnostic Accuracy of Clinical Lymph Node Staging for Upper Tract Urothelial Cancer Patients: A Multicenter, Retrospective, Observational StudyMaximilian Pallauf, Benjamin Pradère, David D‘Andrea et al.|The Journal of Urology|2022Cited by 24
Long‐term multicentre analysis of robot‐assisted radical cystectomy for non‐muscle‐invasive bladder cancerNeeraja Tillu, Peter Wiklund, Reuben Ben‐David et al.|British Journal of Urology|2025Cited by 6